초록 ▼

A method and apparatus for supplying and containing a flow of reducing gas within a fuel cell is disclosed for a fuel cell having a gas control valve system comprising a fuel cell unit, an inlet and an outlet coupled to the fuel cell unit, an actuator disposed in the gas control valve, and a reducin

A method and apparatus for supplying and containing a flow of reducing gas within a fuel cell is disclosed for a fuel cell having a gas control valve system comprising a fuel cell unit, an inlet and an outlet coupled to the fuel cell unit, an actuator disposed in the gas control valve, and a reducing gas supply for actuating said actuator and for regulating fuel to the fuel cell unit.

대표청구항 ▼

A method and apparatus for supplying and containing a flow of reducing gas within a fuel cell is disclosed for a fuel cell having a gas control valve system comprising a fuel cell unit, an inlet and an outlet coupled to the fuel cell unit, an actuator disposed in the gas control valve, and a reducin

A method and apparatus for supplying and containing a flow of reducing gas within a fuel cell is disclosed for a fuel cell having a gas control valve system comprising a fuel cell unit, an inlet and an outlet coupled to the fuel cell unit, an actuator disposed in the gas control valve, and a reducing gas supply for actuating said actuator and for regulating fuel to the fuel cell unit. reof," U.S. patent application Ser. No. 09/929,955, filed Aug. 15, 2001. Sallberg, "A Hepatitis C Virus Non-Structural NS3/4A Fusion Gene," U.S. patent application Ser. No. 09/930,591, filed Aug. 15, 2001. Sidewell et al., "Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide," Science, 177(50):705-706 (1972). Smith et al., "Molecular Engineering of the Autographa californica Nuclear Polyhedrosis Virus Genome: Deletion Mutations Within the Polyhedrin Gene," Journal of Virology, 46:584 (1983). Szybalska and Szybalska, "Genetics of Human Cell Lines, IV. DNA-Mediated Heritable Transformationof a Biochemical Trait," Proc Natl Acad Sci USA, 48:2026 (1962). Takeda et al., "Construction of chimaeric processed immunoglobulin genes containing mouse variable and human constant region sequences," Nature, 314:452-454 (1985). Tan et al., "How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A," Virology, 284(1):1-12 (2001). Vaitukaitis et al., "A method for producing specific antisera with small doses of immunogen," J. Clin. Endocrinology Metab., 33(6):988-991 (1971). Zhang et al., "Characterization of a monoclonal antibody and its singl-chain antibody fragment recongizing the nucleoside triphosphatase/helicase domain of the hepatitis C virus nonstructural 3 protein," Clin. Diagn. Lab. Immunol., 7(1):58-63 (2000). Zhang et al., "Molecular basis for antibody cros-reactivity between the hepatitis C virs core protein and the hos-derived GOR protein," Clin. Exp. Immunol., 96(3):403-409 (1994). Kakumu S., et al. Pilot Study of Ribarvirin and Interferon-β for Chronic Hepatitis B, (1993) Hepatology vol. 18 No. 2 pp. 258-263. Memar O. et al., Antiviral Agents in Dermatology; Current Status and Future Prospects, (1995) Internation Journal of Dermatology, vol. 34, No. 9 pp. 597-606. Tam C. et al., Ribavirin Polarizes Human T Cell Responses Towards a Type 1 Cytokine Profile, (1999) Journal of Hepatology 30:376-382. Ramasamy K.S. et al., Monocyclic L-Nucleosides with Type 1 Cytokine-Inducing Activity, (2000) Journal of Medicinal Chemistry, vol. 43, No. 5 pp. 1019-1028. Wang G. et al., Synthesis and Cytokine Modulation Properties of Pyrrolo[2,3-d]-4-pyrimidone Nucleosides, J. Med. Chem. 43:2566-2574.